Ohio Public Employees Retirement System (OPERS)’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-18
Closed -$105K 2010
2020
Q4
$105K Buy
18
+17
+1,700% +$107K ﹤0.01% 1590
2020
Q3
$5K Hold
1
﹤0.01% 1908
2020
Q2
$5K Hold
1
﹤0.01% 1906
2020
Q1
$7K Sell
1
-1
-50% -$15.7K ﹤0.01% 1838
2019
Q4
$26K Hold
2
﹤0.01% 1837
2019
Q3
$34K Sell
2
-1
-33% -$16.1K ﹤0.01% 1892
2019
Q2
$69K Hold
3
﹤0.01% 1741
2019
Q1
$91K Buy
+3
New +$72K ﹤0.01% 1649

Other funds holding VYNE

Ohio Public Employees Retirement System (OPERS)'s VYNE Position: Q1 2021 in Review

Ohio Public Employees Retirement System (OPERS) sold out of VYNE Therapeutics (VYNE) in Q1 2021, closing a stake of 18 shares — an estimated $105K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in VYNE in Q1 2019 and held it in 8 quarters. The position peaked at $105K in Q4 2020. 81 funds tracked by Wall St. Rank hold VYNE as of Q1 2021.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining VYNE Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 18 VYNE Therapeutics shares in Q1 2021, an estimated $105K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in VYNE Therapeutics in Q1 2019 and held it in 8 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s VYNE Therapeutics position peaked at $105K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q1 2021.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2021, filed 14 May 2021.